Sanofi-Aventis moves account into Euro RSCG

Sanofi-Aventis, the world’s third-largest pharmaceutical company, has awarded a significant part of its advertising business to Havas-owned Euro RSCG.

The company, which has its HQ in France, has appointed Euro RSCG Life, the network’s health division, to oversee communications for its new diabetes brands Lantus and Apidra, and its thrombosis treatment Lovenox/Clexane.

Euro RSCG Life has also been handed responsibility for launching all future marketing programmes for new brands within these two product areas.

It is understood that the account is moving out of Publicis into the Havas-owned network, with Sanofi-Aventis the first global pharmaceutical client to join Euro RSGC Worldwide.

In October, Euro RSCG won the $100m (£52.5m) creative account for Boniva, the drug used in the treatment of osteoporosis, which is jointly owned by Glaxo SmithKline and Hoffmann-LaRoche.

Recommended

A Day in the Life of Jonathan Massey

Marketing Week

Name: Jonathan Massey Company: Pensions Management Job title: Head of Graphic Design What keeps you busy all day? My team look after design jobs from concept to production, including a wide range of products such as magazines, leaflets,…

A1 Holdings names chief executive

Marketing Week

A1 Grand Prix (A1GP), the World Cup of motor sport, has appointed Pete da Silva (pictured) as the new head of its parent company A1 Holdings. He replaces Bruce Holmes, the acting chief executive who has now moved to a different role in the group. Da Silva, who joins in January, will be responsible for […]

Comments

    Leave a comment